Download the case study
Supporting pharmaceutical leaders like GSKDownload the case study
.png?width=3200&height=3200&name=LP%20CS%201-2-3%20(2).png)
As GSK works toward its ambitious environmental goals, including significant reductions in water consumption and carbon emissions across European manufacturing sites, upgrading ageing water treatment infrastructure becomes essential. This case study demonstrates how the right technology partner can deliver immediate efficiency improvements and cost savings while maintaining production continuity and regulatory compliance.
A major global pharmaceutical and healthcare company operating a high-volume manufacturing facility in France needed to replace an ageing water treatment unit that no longer met efficiency standards. The existing system was producing 500 litres per hour but had become costly to maintain, energy-intensive, and water-inefficient. The company required a solution that would maintain pharmaceutical-grade purified water production while significantly improving water and energy efficiency, reducing ongoing maintenance costs, and supporting their sustainability commitments—all without disrupting the production of millions of vital pharmaceutical units manufactured annually for France and global export.
Building on a partnership dating back to 2015, Veolia delivered a solution that immediately improved operational performance and reduced costs. The upgrade achieved 90% water recovery compared to the previous 70%, reduced energy consumption by 10%, and eliminated the need for expensive chemical sanitisation—all while ensuring zero production disruption.
Fill the form to discover how this pharmaceutical manufacturer achieved its objectives
.png?width=1200&height=1400&name=EU%20TDS_GSK_CS%201-2-3%20(1).png)